Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Mar 4;119(9):145-156.
doi: 10.3238/arztebl.m2021.0353.

Pregnancy and Autoimmune Disease

Waltraut Maria Merz  1 , Rebecca Fischer-Betz, Kerstin Hellwig, Georg Lamprecht, Ulrich Gembruch
Affiliations
Review

Pregnancy and Autoimmune Disease

Waltraut Maria Merz et al. Dtsch Arztebl Int. .

Abstract

Background: Pregnancies in women with chronic disease are on the rise. This pertains to autoimmune diseases in particular since these tend to affect women of childbearing age. The interaction between pregnancy and autoimmune disease may increase the risk of maternal, fetal, and obstetric complications; additional care may be required.

Methods: This review is based on a selective literature search in PubMed (2015-2020).

Results: In women with autoimmune diseases, the course of pregnancy is highly variable. Some autoimmune diseases tend to improve during pregnancy and do not to result in any serious obstetric complications. Others may worsen during pregnancy, with deterioration of the maternal condition as well as obstetric and perinatal complications. In systemic lupus erythematosus and myasthenia gravis, placental transfer of specific autoantibodies may cause fetal or neonatal disease.

Conclusion: The care of pregnant women with chronic diseases requires collaboration between specialists of the pertinent levels of care. A stable course of disease before conception, close interdisciplinary care, and pregnancy-compatible medication contribute to a reduction in maternal and perinatal complications.

PubMed Disclaimer

References

    1. Jølving LR, Nielsen J, Kesmodel US, Nielsen RG, Beck-Nielsen SS, Nørgård BM. Prevalence of maternal chronic diseases during pregnancy - a nationwide population based study from 1989 to 2013. Acta Obstet Gynecol Scand. 2016;95:1295–1304. - PubMed
    1. Kersten I, Lange AE, Haas JP, et al. Chronic diseases in pregnant women: prevalence and birth outcomes based on the SNiP-study. BMC Pregnancy Childbirth. 2014;14 - PMC - PubMed
    1. Brown CC, Adams CE, George KE, Moore JE. Associations between comorbidities and severe maternal morbidity. Obstet Gynecol. 2020;136:892–901. - PMC - PubMed
    1. Knight M, Bunch K, Tuffnell D, et al. Saving lives, improving mothers’ care: lessons learned to inform maternity care from the UK and Ireland confidential enquiries into maternal deaths and morbidity. Oxford. 2019:2015–2017.
    1. Richtlinien des Gemeinsamen Bundesausschusses über die ärztliche Betreuung während der Schwangerschaft und nach der Entbindung („Mutterschafts-Richtlinien“) In der Fassung vom 10. Dezember 1985 (veröffentlicht im Bundesanzeiger Nr. 60 a vom 27. März 1986) zuletzt geändert am 20. August 2020 veröffentlicht im Bundesanzeiger AT 23.11.2020 B3 in Kraft getreten am 24. November 2020